QuidelOrtho (QDEL) Net Income towards Common Stockholders (2021 - 2026)

QuidelOrtho (QDEL) reported Net Income towards Common Stockholders of $700000.0 for Q1 2026, up 118.92% on a YoY basis from $319753.1 in Q1 2025, and up 177.78% sequentially from -$900000.0 in Q4 2025.

QuidelOrtho (QDEL) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

QuidelOrtho (QDEL) has 6 years of Net Income towards Common Stockholders data on file, last reported at $700000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Net Income towards Common Stockholders rose 118.92% year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at -$6.7 million (up 67.32% YoY), and the FY2025 full-year result was -$11.1 million, up 99.46% from the prior year.
  • Net Income towards Common Stockholders improved to $700000.0 in Q1 2026, from -$900000.0 in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $479.9 million in Q2 2022 to a low of -$1.7 billion in Q1 2024.
  • A 5-year average of -$97.0 million and a median of -$3.6 million in 2025 frame the typical range for Net Income towards Common Stockholders.
  • Across the five-year window, Net Income towards Common Stockholders plunged 3607.99% in 2024 and soared 118.92% in 2026, its largest moves.
  • Tracing QDEL's Net Income towards Common Stockholders over 5 years: stood at $19.2 million in 2022, then tumbled by 2892.19% to -$536.1 million in 2023, then jumped by 99.29% to -$3.8 million in 2024, then jumped by 76.32% to -$900000.0 in 2025, then jumped by 177.78% to $700000.0 in 2026.
  • Business Quant data shows QDEL's Net Income towards Common Stockholders at $700000.0 in Q1 2026, -$900000.0 in Q4 2025, and -$2.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 1.08 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 745.00 Mn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 1.26 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 1.34 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn -
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 199.50 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 411.00 Mn
8 Smith & Nephew 26.99 Bn 26.41 Bn - -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 176.78 Mn
10 QuidelOrtho 1.15 Bn 1.01 Bn - 700,000.00

Historic Data

Download Data
DateValue
Mar 29, 2026 700,000.00
Dec 28, 2025 -900,000.00
Sep 28, 2025 -2.90 Mn
Jun 29, 2025 -3.60 Mn
Mar 30, 2025 -3.70 Mn
Dec 29, 2024 -3.80 Mn
Sep 29, 2024 -6.80 Mn
Jun 30, 2024 -6.20 Mn
Mar 31, 2024 -1.71 Bn
Dec 31, 2023 -536.10 Mn
Oct 1, 2023 -19.00 Mn
Jul 2, 2023 -57.50 Mn
Apr 2, 2023 48.80 Mn
Jan 1, 2023 135.80 Mn
Oct 2, 2022 19.20 Mn
Jul 3, 2022 19.30 Mn
Apr 3, 2022 479.90 Mn
Oct 3, 2021 215.70 Mn
Jul 4, 2021 19.10 Mn